Atrium Therapeutics, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
13.00
-0.09 (-0.69%)
May 26, 2026, 1:42 PM EDT - Market open
Atrium Therapeutics Market Cap
Atrium Therapeutics has a market cap or net worth of $222.37 million as of May 26, 2026.
Market Cap
222.37M
Enterprise Value
-41.26M
1-Year Change
n/a
Ranking
Category
Stock Price
$13.00
Market Cap Chart
Since February 27, 2026, Atrium Therapeutics's market cap has decreased from $228.85M to $222.37M, a decrease of -2.83%. That is a compound annual growth rate of -11.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 223.91M | 0.38% |
| May 21, 2026 | 223.06M | 2.52% |
| May 20, 2026 | 217.58M | -1.78% |
| May 19, 2026 | 221.52M | - |
| May 18, 2026 | 221.52M | -2.12% |
| May 15, 2026 | 226.31M | -0.30% |
| May 14, 2026 | 226.99M | 10.00% |
| May 13, 2026 | 206.35M | 1.22% |
| May 12, 2026 | 203.87M | -0.83% |
| May 11, 2026 | 205.57M | 1.38% |
| May 8, 2026 | 202.78M | 0.85% |
| May 7, 2026 | 201.07M | -0.99% |
| May 6, 2026 | 203.09M | 1.39% |
| May 5, 2026 | 200.30M | 0.31% |
| May 4, 2026 | 199.68M | -4.17% |
| May 1, 2026 | 208.37M | 5.17% |
| Apr 30, 2026 | 198.13M | -1.69% |
| Apr 29, 2026 | 201.54M | 3.51% |
| Apr 28, 2026 | 194.71M | -2.71% |
| Apr 27, 2026 | 200.14M | -4.37% |
| Apr 24, 2026 | 209.30M | -2.60% |
| Apr 23, 2026 | 214.88M | 1.39% |
| Apr 22, 2026 | 211.93M | 0.96% |
| Apr 21, 2026 | 209.92M | -5.38% |
| Apr 20, 2026 | 221.86M | -0.76% |
| Apr 17, 2026 | 223.57M | 2.71% |
| Apr 16, 2026 | 217.67M | -3.51% |
| Apr 15, 2026 | 225.59M | 3.71% |
| Apr 14, 2026 | 217.52M | 5.41% |
| Apr 13, 2026 | 206.35M | 4.64% |
| Apr 10, 2026 | 197.20M | -7.36% |
| Apr 9, 2026 | 212.87M | 0.15% |
| Apr 8, 2026 | 212.56M | -2.07% |
| Apr 7, 2026 | 217.05M | 2.34% |
| Apr 6, 2026 | 212.09M | 1.71% |
| Apr 2, 2026 | 208.52M | -0.22% |
| Apr 1, 2026 | 208.99M | 0.75% |
| Mar 31, 2026 | 207.44M | -1.33% |
| Mar 30, 2026 | 210.23M | 2.42% |
| Mar 27, 2026 | 205.26M | 0.99% |
| Mar 26, 2026 | 203.25M | 0.08% |
| Mar 25, 2026 | 203.09M | -0.83% |
| Mar 24, 2026 | 204.80M | - |
| Mar 23, 2026 | 204.80M | 0.53% |
| Mar 20, 2026 | 203.71M | 3.47% |
| Mar 19, 2026 | 196.88M | 3.00% |
| Mar 18, 2026 | 191.14M | -10.53% |
| Mar 17, 2026 | 213.64M | -0.15% |
| Mar 16, 2026 | 213.95M | 0.29% |
| Mar 13, 2026 | 213.33M | -5.43% |
| Mar 12, 2026 | 225.59M | -1.76% |
| Mar 11, 2026 | 229.62M | 0.89% |
| Mar 10, 2026 | 227.60M | -0.81% |
| Mar 9, 2026 | 229.47M | -0.20% |
| Mar 6, 2026 | 229.93M | -4.20% |
| Mar 5, 2026 | 240.02M | -6.47% |
| Mar 4, 2026 | 256.62M | 5.55% |
| Mar 3, 2026 | 243.12M | 5.10% |
| Mar 2, 2026 | 231.33M | 1.08% |
| Feb 27, 2026 | 228.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Camp4 Therapeutics | 234.19M |
| Cybin | 234.17M |
| Humacyte | 233.12M |
| Voyager Therapeutics | 229.60M |
| Codexis | 226.33M |
| Whitehawk Therapeutics | 221.93M |
| Keros Therapeutics | 221.47M |
| NervGen Pharma | 218.26M |